HHV-8 seroprevalence: A global view

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Rohner, Eliane ^a   Wyss, Natascha ^a   Trelle, Sven ^a   Mbulaiteye, Sam M ^b   Egger, Matthias ^a,c   Novak, Urban ^d   Zwahlen, Marcel ^a   Bohlius, Julia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d PSI   (Switzerland)

Author keywords

HHV 8; HIV; Kaposi sarcoma; Meta analysis; Seroprevalence

Indexed keywords

ARTICLE; COMORBIDITY; ETHNICITY; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; META ANALYSIS; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RISK FACTOR; SCIENTIFIC LITERATURE; SEROPREVALENCE; SEXUAL ORIENTATION; SOCIOECONOMICS; SYSTEMATIC REVIEW; ADULT; CHILD; EPIDEMIOLOGY; MALE; MALE HOMOSEXUALITY; REVIEW; STATISTICS; VIROLOGY;

ADULT; CHILD; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HOMOSEXUALITY, MALE; HUMANS; MALE; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

EID: 84907258511     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-11     Document Type: Article

References (55)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869. 10.1126/science.7997879, 7997879.
2. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802. 10.1016/S0140-6736(95)91619-9, 7674745.
3. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996, 2:918-924. 10.1038/nm0896-918, 8705863.
4. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948-954. 10.1056/NEJM199804023381403, 9521982.
5. O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999, 180:1010-1017. 10.1086/315039, 10479125.
6. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, D'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
7. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191. 10.1056/NEJM199505043321802, 7700311.
8. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Biological Agents, Volume 100 B, A Review of Human Carcinogen 2012, Lyon, France: International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.
9. Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer 2006, 119:2685-2691. 10.1002/ijc.22233, 16929513.
10. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?. Lancet 1990, 335:123-128. 10.1016/0140-6736(90)90001-L, 1967430.
11. Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 2005, 23:1253-1260. 10.1200/JCO.2005.04.156, 15718323.
12. Semeere AS, Busakhala N, Martin JN. Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings. Curr Opin Oncol 2012, 24:522-530. 10.1097/CCO.0b013e328355e14b, 3418488, 22729153.
13. Dal ML, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001, 37:1188-1201. 10.1016/S0959-8049(01)00120-4, 11423251.
14. Orem J, Otieno MW, Remick SC. AIDS-associated cancer in developing nations. Curr Opin Oncol 2004, 16:468-476. 10.1097/00001622-200409000-00010, 15314517.
15. Biryahwaho B, Dollard SC, Pfeiffer RM, Shebl FM, Munuo S, Amin MM, Hladik W, Parsons R, Mbulaiteye SM. Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population-based sample in Uganda. J Infect Dis 2010, 202:1347-1353. 10.1086/656525, 2949503, 20863232.
16. Butler LM, Were WA, Balinandi S, Downing R, Dollard S, Neilands TB, Gupta S, Rutherford GW, Mermin J. Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis 2011, 203:625-634. 10.1093/infdis/jiq092, 3071279, 21273188.
17. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007, 196:199-207. 10.1086/518791, 17570106.
18. Regamey N, Cathomas G, Schwager M, Wernli M, Harr T, Erb P. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 1998, 36:1784-1786. 104922, 9620422.
19. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998, 90:395-397. 10.1093/jnci/90.5.395, 9498490.
20. Geddes M, Franceschi S, Barchielli A, Falcini F, Carli S, Cocconi G, Conti E, Crosignani P, Gafà L, Giarelli L, Vercelli M, Zanetti R. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 1994, 69:333-336. 10.1038/bjc.1994.60, 1968687, 8297730.
21. Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999, 81:893-897. 10.1038/sj.bjc.6690782, 2374301, 10555764.
22. Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, Coutinho RA, Goudsmit J. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 2000, 151:213-224. 10.1093/oxfordjournals.aje.a010195, 10670545.
23. De Tejada BM, Steffen I, Cantero P, Posfay Barbe KM, Irion O, Hirschel B, Boffi El Amari E. Human herpes virus type 8 seroprevalence in pregnant women in Geneva, Switzerland. J Matern Fetal Neonatal Med 2011, 24:183-185. 10.3109/14767058.2010.482623, 20569167.
24. Reinheimer C, Allwinn R, Sturmer M. Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?. Med Microbiol Immunol 2011, 200:161-164. 10.1007/s00430-011-0187-0, 21336596.
25. Parisi SG, Sarmati L, Pappagallo M, Mazzi R, Carolo G, Farchi F, Nicastri E, Concia E, Rezza G, Andreoni M. Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. J Acquir Immune Defic Syndr 2002, 29:295-299. 10.1097/00126334-200203010-00011, 11873080.
26. Nuvor SV, Katano H, Ampofo WK, Barnor JS, Sata T. Higher prevalence of antibodies to human herpesvirus 8 in HIV-infected individuals than in the general population in Ghana, West Africa. Eur J Clin Microbiol Infect Dis 2001, 20:362-364.
27. Klaskala W, Brayfield BP, Kankasa C, Bhat G, West JT, Mitchell CD, Wood C. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 2005, 75:93-100. 10.1002/jmv.20242, 15543582.
28. He J, Bhat G, Kankasa C, Chintu C, Mitchell C, Duan W, Wood C. Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect Dis 1998, 178:1787-1790. 10.1086/314512, 9815235.
29. Baeten JM, Chohan BH, Lavreys L, Rakwar JP, Ashley R, Richardson BA, Mandaliya K, Bwayo JJ, Kreiss JK. Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya. AIDS 2002, 16:2073-2078. 10.1097/00002030-200210180-00013, 12370507.
30. Valdarchi C, Serraino D, Cordiali FP, Castilletti C, Trento E, Farchi F, Rezza G,. General Practitioner Study Group Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy. Infection 2007, 35:22-25. 10.1007/s15010-007-5123-2, 17297585, General Practitioner Study Group.
31. Pfeiffer RM, Wheeler WA, Mbisa G, Whitby D, Goedert JJ, de Thé G, Mbulaiteye SM. Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology. Ann Epidemiol 2010, 20:958-963. 10.1016/j.annepidem.2010.07.098, 21074111.
32. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, Bakaki PM, Gamache C, Owor AM, Katongole-Mbidde E, Ndugwa CM, Goedert JJ, Whitby D, Engels EA. Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr 2005, 38:474-479. 10.1097/01.qai.0000132495.89162.c0, 15764964.
33. Wakeham K, Webb EL, Sebina I, Nalwoga A, Muhangi L, Miley W, Johnston WT, Ndibazza J, Whitby D, Newton R, Elliott AM. Risk factors for seropositivity to Kaposi's sarcoma associated herpesvirus (KSHV) among children in Uganda. J Acquir Immune Defic Syndr 2013, 63:228-233. 10.1097/QAI.0b013e31828a7056, 3707567, 23403859.
34. Mbulaiteye SM, Goedert JJ. Transmission of Kaposi sarcoma-associated herpesvirus in sub-Saharan Africa. AIDS 2008, 22:535-537. 10.1097/QAD.0b013e3282f4352e, 18301068.
35. Anderson LA, Li Y, Graubard BI, Whitby D, Mbisa G, Tan S, Goedert JJ, Engels EA. Human herpesvirus 8 seroprevalence among children and adolescents in the United States. Pediatr Infect Dis J 2008, 27:661-664. 10.1097/INF.0b013e3181691740, 18536622.
36. Plancoulaine S, Abel L, Van BM, Tregouet DA, Joubert M, Tortevoye P, De Thé G, Gessain A. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000, 356:1062-1065. 10.1016/S0140-6736(00)02729-X, 11009141.
37. Minhas V, Crabtree KL, Chao A, M'soka TJ, Kankasa C, Bulterys M, Mitchell CD, Wood C. Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am J Epidemiol 2008, 168:311-320. 10.1093/aje/kwn125, 2727264, 18515794.
38. Butler LM, Dorsey G, Hladik W, Rosenthal PJ, Brander C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard SC, Martin JN. Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis 2009, 200:430-438. 10.1086/600103, 19534596.
39. Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, Hawes SE, Critchlow CW, Morrow RA, Corey L, Kiviat N, Wald A. HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr 2004, 35:233-238. 10.1097/00126334-200403010-00003, 15076237.
40. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000, 343:1369-1377. 10.1056/NEJM200011093431904, 11070101.
41. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998, 178:304-309. 10.1086/515649, 9697708.
42. Zhang T, Shao X, Chen Y, Zhang T, Minhas V, Wood C, He N. Human herpesvirus 8 seroprevalence, China. Emerg Infect Dis 2012, 18:150-152. 10.3201/eid1801.102070, 3310085, 22257662.
43. Cochrane Handbook for Systematic Reviews of Interventions 2011, The Cochrane Collaboration, Higgins JPT, Green S, Version 5.1.0 [updated March 2011], Available from http://www.cochrane-handbook.org.
44. Moher D, Liberati A, Tetzlaff J, Altman DG,. PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072, PRISMA Group.
45. National Institute for Health and Clinical Excellence Methods for the development of NICE public health guidance (third edition, 2012) Available from http://publications.nice.org.uk/methods-for-the-development-of-nice-public-health-guidance-third-edition-pmg4, National Institute for Health and Clinical Excellence.
46. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW, Atkins D, Meerpohl J, Schünemann HJ. GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias). J Clin Epidemiol 2011, 64:407-415. 10.1016/j.jclinepi.2010.07.017, 21247734.
47. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999, 282:1054-1060. 10.1001/jama.282.11.1054, 10493204.
48. Spiegelhalter D, Abrams K, Myles J. Bayesian Approaches to Clinical Trials and Health-Care Evaluation 2004, Hoboken, NJ: John Wiley & Sons.
49. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr 2000, 23:346-354. 10.1097/00126334-200004010-00011, 10836758.
50. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, Kite-Powell K, Pellett PE. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000, 38:2174-2180. 86757, 10834972.
51. Perez C, Tous M, Benetucci J, Gomez J. Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations. J Med Virol 2006, 78:806-813. 10.1002/jmv.20627, 16628571.
52. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med 2005, 24:2401-2428. 10.1002/sim.2112, 16015676.
53. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Anal 2006, 1:515-533.
54. Brooks S, Gelman A. Alternative methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998, 7:434-455.
55. Wu TT, Qian J, Ang J, Sun R. Vaccine prospect of Kaposi sarcoma-associated herpesvirus. Curr Opin Virol 2012, 2:482-488. 10.1016/j.coviro.2012.06.005, 22795202.